PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC10004598::ACT000056

P1

Evidence text

Paper-level observation

Section 2.10: 20 μg/mL of Hydrostatin-AMP2 could reduce iNOS expression by 87.5%.
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Anti-inflammatory
Measure
percent_inhibition
Comparator
=
Raw observation
87.5%
Normalized measurement
=87.5%
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Mus musculus
Assay method
Not reported by source
Sequence
KRFKKFFKKLRKSVKKRVKKFFKKPKVIGVSIPF
Standardization
ready simple

Source publication

Identification and Characterization of a Novel Cathelicidin from Hydrophis cyanocinctus with Antimicrobial and Anti-Inflammatory Activity

Molecules · 2023

DOI 10.3390/molecules28052082 PMC10004598
Parent mention Integrated peptide

Related peptide identities

PEPDIA-PLP-003777PEPDIA-INT-004630

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.